NASDAQ:SNBP

Sun BioPharma (SNBP) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$0.41
$0.48
50-Day Range
$3.45
$4.50
52-Week Range
$2.37
$10.00
Volume
25,779 shs
Average Volume
26,926 shs
Market Capitalization
$4.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Sun BioPharma

Sun BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics treatment for unmet medical needs. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. Sun BioPharma, Inc. was founded in 2011 and is based in Waconia, Minnesota.

SNBP Stock News Headlines

What is Medicare Supplement Insurance?
Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you.
ABUS Arbutus Biopharma Corporation
What is Medicare Supplement Insurance?
Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you.
Tips for staying safe in the sun
Sun Pharmaceutical Industries Ltd. (SUN)
See More Headlines
Receive SNBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sun BioPharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/12/2020
Today
4/26/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:SNBP
CIK
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$4.25 million
Optionable
Not Optionable
Beta
N/A
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

  • Dr. Michael T. Cullen Jr. (Age 74)
    Co-Founder & Exec. Chairman
    Comp: $282.35k
  • Ms. Susan Horvath (Age 61)
    VP of Fin., CFO, Sec. & Treasurer
    Comp: $220.31k
  • Dr. Jennifer K. Simpson (Age 52)
    CEO, Pres & Director
  • Dr. Thomas X. Neenan
    Co-Founder & Chief Scientific Officer
  • Ms. Tammy Groene
    VP of Operations
  • Dr. Suzanne Gagnon (Age 63)
    Chief Medical Officer & Director

SNBP Stock Analysis - Frequently Asked Questions

How were Sun BioPharma's earnings last quarter?

Sun BioPharma, Inc. (NASDAQ:SNBP) released its quarterly earnings results on Thursday, November, 12th. The company reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.12) by $0.09.

What other stocks do shareholders of Sun BioPharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sun BioPharma investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Kaleido Biosciences (KLDO).

This page (NASDAQ:SNBP) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners